Literature DB >> 18045388

The application of chromogenic media in clinical microbiology.

J D Perry1, A M Freydière.   

Abstract

Since 1990, a wide range of chromogenic culture media has been made commercially available providing useful tools for diagnostic clinical microbiology. By the inclusion of chromogenic enzyme substrates targeting microbial enzymes, such media are able to target pathogens with high specificity. Examples of target pathogens include Staphylococcus aureus, Streptococcus agalactiae, Salmonella spp. and Candida spp. The inclusion of multiple chromogenic substrates into culture media facilitates the differentiation of polymicrobial cultures, thus allowing for the development of improved media for diagnosis of urinary tract infections and media for the enhanced discrimination of yeasts. The purpose of this review is to provide some insight into how such media work and appraise their utility in routine clinical diagnostics, in comparison with conventional media.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045388     DOI: 10.1111/j.1365-2672.2007.03442.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  21 in total

1.  Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus.

Authors:  M F Q Kluytmans-van den Bergh; M C Vos; B M W Diederen; C M J E Vandenbroucke-Grauls; A Voss; J A J W Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-27       Impact factor: 3.267

2.  Evaluation of New bioMérieux Chromogenic CPS Media for Detection of Urinary Tract Pathogens.

Authors:  Josselin Rigaill; Paul O Verhoeven; Caroline Mahinc; Mohamed Jeraiby; Florence Grattard; Nathalie Fonsale; Bruno Pozzetto; Anne Carricajo
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

Review 3.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  CHROMagar Orientation medium reduces urine culture workload.

Authors:  Kanchana Manickam; James A Karlowsky; Heather Adam; Philippe R S Lagacé-Wiens; Assunta Rendina; Paulette Pang; Brenda-Lee Murray; Michelle J Alfa
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

5.  Development of an improved selective and differential medium for isolation of Salmonella spp.

Authors:  Sang-Hyun Park; Sangryeol Ryu; Dong-Hyun Kang
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

6.  Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours.

Authors:  John D Perry; Kerry Asir; Diane Halimi; Sylvain Orenga; Joanne Dale; Michelle Payne; Ruth Carlton; Jim Evans; F Kate Gould
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

7.  Evaluation of a new chromogenic medium (StrepB select) for detection of group B Streptococcus from vaginal-rectal specimens.

Authors:  L Louie; L Kotowich; H Meaney; M Vearncombe; A E Simor
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

8.  Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus.

Authors:  Surbhi Malhotra-Kumar; José Cortinas Abrahantes; Wilber Sabiiti; Christine Lammens; Greetje Vercauteren; Margareta Ieven; Geert Molenberghs; Marc Aerts; Herman Goossens
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

9.  Comparison of Six Chromogenic Agar Media for the Isolation of a Broad Variety of Non-O157 Shigatoxin-Producing Escherichia coli (STEC) Serogroups.

Authors:  Bavo Verhaegen; Koen De Reu; Marc Heyndrickx; Lieven De Zutter
Journal:  Int J Environ Res Public Health       Date:  2015-06-17       Impact factor: 3.390

10.  Comparison of ChromID agar and Clostridium difficile selective agar for effective isolation of C. difficile from stool specimens.

Authors:  Bo-Moon Shin; Eun Joo Lee
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.